Choroideremia (CHM) is an X-linked form of retinal degeneration, caused by loss of function mutations in the CHM gene that encodes Rab Escort Protein 1 gene (REP1). REP1 is a key regulator of vesicular trafficking, phagosome fusion, and maturation. We investigated the effects of different CHM mutations in monocytes derived from CHM patients. Phagocytosis in monocytes was tracked with a pH-dependent dye conjugated with E. coli, and the rate of degradation of engulfed material was determined using labeled DQTM-Ovalbumin (Molecular Probes, Eugene, OR). Monocytes (CD14+ fraction) from 6 age-matched controls and 3 CHM patients (brothers) with the same mutation in CHM were compared for different aspects of intracellular vesicle transport. The three brothers demonstrated a large degree of variability in trafficking defects and serum levels of PEDF, VEGF, and MCP1 factors, which correlated with the clinical severity of their disease. We demonstrated that peripheral cells from CHM patients have characteristic defects that have not previously been recognized and could be used as alternative models to study the cellular effects of different mutations in the CHM gene and the mechanisms surrounding the progressive retinal degeneration in this condition.
CSNB CSNB1A CSNB2A CANA1FNYXGRM6TRMP1
This is a preview of subscription content, log in to check access.
Becq F (2010) Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Drugs 70:241–259PubMedCrossRefGoogle Scholar
Gordiyenko NV, Fariss RN, Zhi C et al (2009) Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 51:1143–1150PubMedCrossRefGoogle Scholar
Jacobson SG, Cideciyan AV, Sumaroka A et al (2006) Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 47:4113–4120PubMedCrossRefGoogle Scholar
Moosajee M, Gregory-Evans K, Ellis CD et al (2008) Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Hum Mol Genet 17:3987–4000PubMedCrossRefGoogle Scholar
Rak A, Pylypenko O, Niculae A et al (2004) Structure of the Rab7:REP-1 complex: insights into the mechanism of Rab prenylation and choroideremia disease. Cell 117:749–760PubMedCrossRefGoogle Scholar
Reynolds R, Hartnett ME, Atkinson JP et al (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50:5818–5827PubMedCrossRefGoogle Scholar
Rudolph G, Preising M, Kalpadakis P et al (2003) Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet 24:203–214PubMedCrossRefGoogle Scholar
Sieving PA, Niffenegger JH, Berson EL (1986) Electroretinographic findings in selected pedigrees with choroideremia. Am J Ophthalmol 101:361–367PubMedGoogle Scholar
Strunnikova NV, Barb J, Sergeev YV et al (2009) Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients. PLoS One 4:e8402PubMedCrossRefGoogle Scholar
Tolmachova T, Anders R, Abrink M et al (2006) Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest 116:386–394PubMedCrossRefGoogle Scholar